User:Etchevers/Notebook/Conference notes/2009/09/15: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(Autocreate 2009/09/15 Entry for User:Etchevers/Notebook/Conference_notes)
 
Line 7: Line 7:
<!-- ##### DO NOT edit above this line unless you know what you are doing. ##### -->
<!-- ##### DO NOT edit above this line unless you know what you are doing. ##### -->


==Notes for (enter conference or seminar) ==
== Fourth day of 6th Intl Neural Tube Defects conference ==


* Insert content here...
=== Alex Massuk - Intl Spina Bifida Genomics Consortium to detect CNVs ===


I slept through it :-(
But there is already a consortium set up, with some 30-odd investigators associated, cf the abstract. Alison and Simon are contibuting some 150-ish samples from Marcy's collection, perhaps some are better quality than others and more adapted to this analysis. Will use aCGH (what they call here "CGH array"?) and in theory can recycle the arrays up to 5x. Would need to ask Damien about this technology, or Laurence.
=== Larry Brody and Anne Molloy - Genome-wide association study ===
Complementary to the CNV study
lbrody at helix.nih.gov
amolloy at tcd.ie
Center for Inherited Disease Research [http://www.cidr.jhmi.edu/ http://www.cidr.jhmi.edu] - lots of tools. >99.9% success in hybridization (?). Lower resolution than CGH array. Can pick up large homozygosity regions though.
Omni Quad arrays - $425 per sample, expect costs of about $1.25 million and then later costs for follow-up.  To collaborate, cost will be that of sample preps.  Want to screen >1000 cases and controls or trios.
If odds ratios 1.5-2 then only getting some info. Requirement for replication set to be established at the same time (John Gilbert thinks this is somewhat spurious, perhaps preferable to increase power by including them to begin with). Wide data release anticipated need to keep this idea when thinking of consentments for human subjects.
Have 653 Irish trios, 367 English and 56049 controls (I think from the Wellcome Trust) - also have a genotyping tech and statisticians, can perform follow-up genotyping in the Brody group.
Get back: detailed SNP info for your favorite gene in your favorite region. Questions about population stratification and clinical heterogeneity, or heterogeneous exposure conditions? - wants to be as inclusive as possible. Anyone with a cohort >30 is welcome. Currently will combine cranial and caudal NTDs and split out later, but study design is still being thought out.
Are they planning a system to manage the associated clinical data? Yes, idea of a project website for data entry, Brody can underwrite the administrative and other infrastructure costs. Costs for sample shipping, perhaps meetings... [http://www.cidr.jhmi.edu/ CIDR] projects are different funding mechanism than P01 or R01s.


<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
<!-- ##### DO NOT edit below this line unless you know what you are doing. ##### -->
|}
|}
__NOTOC__

Revision as of 06:59, 21 September 2009

Conference and seminar notes <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page
<html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html>

Fourth day of 6th Intl Neural Tube Defects conference

Alex Massuk - Intl Spina Bifida Genomics Consortium to detect CNVs

I slept through it :-(

But there is already a consortium set up, with some 30-odd investigators associated, cf the abstract. Alison and Simon are contibuting some 150-ish samples from Marcy's collection, perhaps some are better quality than others and more adapted to this analysis. Will use aCGH (what they call here "CGH array"?) and in theory can recycle the arrays up to 5x. Would need to ask Damien about this technology, or Laurence.

Larry Brody and Anne Molloy - Genome-wide association study

Complementary to the CNV study

lbrody at helix.nih.gov amolloy at tcd.ie

Center for Inherited Disease Research http://www.cidr.jhmi.edu - lots of tools. >99.9% success in hybridization (?). Lower resolution than CGH array. Can pick up large homozygosity regions though.

Omni Quad arrays - $425 per sample, expect costs of about $1.25 million and then later costs for follow-up. To collaborate, cost will be that of sample preps. Want to screen >1000 cases and controls or trios.

If odds ratios 1.5-2 then only getting some info. Requirement for replication set to be established at the same time (John Gilbert thinks this is somewhat spurious, perhaps preferable to increase power by including them to begin with). Wide data release anticipated need to keep this idea when thinking of consentments for human subjects.

Have 653 Irish trios, 367 English and 56049 controls (I think from the Wellcome Trust) - also have a genotyping tech and statisticians, can perform follow-up genotyping in the Brody group.

Get back: detailed SNP info for your favorite gene in your favorite region. Questions about population stratification and clinical heterogeneity, or heterogeneous exposure conditions? - wants to be as inclusive as possible. Anyone with a cohort >30 is welcome. Currently will combine cranial and caudal NTDs and split out later, but study design is still being thought out.

Are they planning a system to manage the associated clinical data? Yes, idea of a project website for data entry, Brody can underwrite the administrative and other infrastructure costs. Costs for sample shipping, perhaps meetings... CIDR projects are different funding mechanism than P01 or R01s.